Background Information

• Adherence (AIDS InfoNet) and Spanish version
• Keeping up with your meds: Adherence (Project Inform) and Spanish version
• Taking your treatment – adherence (AIDSmap)

Selected Recent Articles

• The Undetectable Problem 1: Trauma and Adherence.  (September 2016, TheBodyPro)
• 7 Ways to Improve Adherence.  (September 2016, Poz)
• Why Adherence Is Important.  (September 2016, Poz)
• U.S. PrEP study achieves high levels of engagement and adherence among black men who have sex with men.  (August 2016, AIDSmap)
• Increasing adherence, tailoring interventions may reduce disparities in PrEP uptake.  (August 2016, Healio)
• Adherence Clubs Promote Retention, HIV Control in Randomized Johannesburg Trial.  (August 2016, TheBodyPro)
• TAF, combination regimens improve outcomes in HIV, but challenges remain.  (July 2016, Healio)
• Asking About Missed Doses Triples Antiretroviral Nonadherence Disclosure.  (July 2016, TheBodyPro)
• Major PrEP Studies Underline Importance of Adherence.  (June 2016, Poz)
• PrEP-Linked Symptoms Peak in First Month, With Modest Adherence Impact.  (June 2016, TheBodyPro)
• In Option B+, side-effects and needing time to think are key reasons for not taking HIV medication.  (May 2016, AIDSmap)
• Late Diagnosis, Adherence to Tx Problematic for Latinos With HIV. (April 2016, MedPage Today)
• People who use drugs still adherent to PrEP.  (April 2016, Beta Blog)
• African women in London with poor adherence feel that HIV treatment is difficult and unrelenting.  (April 2016, AIDSmap)
• In Louisiana Jails, with HIV and No Help: Limited Testing, Treatment Interruptions Endanger Detainees.  (March 2016, Human Rights Watch)
• Self-Reported Suboptimal Adherence Tied to Rebound on Next Viral Load Measure.  (March 2016, TheBodyPro)
• Women Need to Adhere Better to PrEP Than Men to Be Protected Against HIV.  (March 2016, Poz)
• ‘Explosion of options’ in single-tablet regimens for HIV benefits patients, providers.  (March 2016, Healio)
• NIH-funded study finds critical population adheres to PrEP with coordinated care (February 2016, National Institute of Allergy and Infectious Diseases)
• What is a drug “tail,” and what does it have to do with long-acting PrEP?  (February 2016, Beta Blog)
• Taking Multiple Non-HIV Drugs Linked to Antiretroviral Treatment Breaks.  (February 2016, TheBodyPro)
• Taking Many Non-HIV Meds Is Linked to Shifts, Gaps in HIV Treatment.  (February 2016, Poz)
• ‘Start-up syndrome’ affects some Truvada users for short period.  (January 2016, Healio)
• People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs.  (January 2016, AIDSmap)
• The Challenges of Assessing Guideline Adherence in a Rapidly Changing Treatment Landscape.  (December 2015, TheBodyPro)
• Treatment Adherence Optimization: Acting With Humility to Move Beyond Preconceived Ideas.  (October 2015, TheBodyPro)
• Recent infection and ART treatment interruptions are key periods for HIV transmission.  (October 2015, AIDSmap)
• Skipping HIV Meds While Abusing Drugs? Think Again.  (August 2015, Poz)
• Third of people with HIV who use drugs intentionally miss doses of HIV treatment when planning to use drugs.  (August 2015, AIDSmap)
• Open-label PrEP in Botswana: very high adherence and no HIV infections seen.  (August 2015, AIDSmap)
• Patching the Leaky Cascade: Report From the 2015 Adherence Conference. (July 2015, TheBodyPro)
• PrEP demo project finds the people at highest HIV risk generally take PrEP most consistently.  (July 2015, AIDSmap)
• Daily dosing and text message reminders associated with PrEP adherence in gay men.  (July 2015, Project Inform)
• Gay youth PrEP study finds good retention and reasonable adherence.  (July 2015, AIDSmap)
• HIV “Adherence Clubs” Help People Stay In Care.  (July 2015, Beta Blog)
• Intervention Ups Adherence to HIV Meds, Reduces Viral Load.  (July 2015, Poz)
• People with Housing and Higher HIV Risk are More Adherent to PrEP.  (July 2015, Beta Blog)
• ATN 110: PrEP Adherence Challenges of Young Black Gay Men.  (July 2015, Beta Blog)
• New PrEP & women studies: High adherence and effectiveness, but caution for providers.  (July 2015, Project Inform)
• Excellent Adherence, No New HIV Cases in Heterosexual PrEP Trial.  (July 2015, Poz)
• Gay and Bi Men Adhere Well to PrEP in U.S. Real-World Study.  (July 2015, Poz)
• Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing.  (July 2015, AIDSmap)
• HIV PEP with emtricitabine/tenofovir/rilpivirine has excellent completion and adherence rates.  (July 2015, AIDSmap)
• Black market for Truvada PrEP may undermine treatment adherence in marginalised people living with HIV.  (July 2015, AIDSmap)
• Second-line ART patients reach viral re-suppression following intensified adherence support.  (July 2015, AIDSmap)
• Community-based adherence clubs show high retention in HIV care and treatment adherence.  (July 2015, AIDSmap)
• Microclinics improve adherence to clinic care in HIV patients.  (May 2015, Healio)
• Newer Non-Nuke HIV Meds May Allow for Lower Adherence.  (May 2015, Poz)
• Modern NNRTI regimens can be effective with 85% adherence.  (May 2015, AIDSmap)
• HIV behavioral intervention boosts ART adherence in minorities.  (May 2015, Healio)
• Individual HIV Meds Are Just as Effective as Combo Pills.  (May 2015, Poz)
• Opioid Substitution Treatment Ups Adherence to HIV Meds.  (April 2015, Poz)
• Women in Failed PrEP Trial Lied About Pill Use to Stay In Study.  Articled dated April 2015, Poz)
• Treatment outcomes no better with single tablet regimens than individual tablets.  (April 2015, AIDSmap)
• Daily PrEP leads to better adherence and protective drug levels in women.  (April 2015, AIDSmap)
• Good Mental Health Likely Means Good Adherence to HIV Meds.  (April 2015, Poz)
• Intervention Improves HIV Med Adherence Among Blacks and Latinos.  (April 2015, Poz)
• Women in PrEP trial feared they would have to leave study if they reported low adherence.  (April 2015, AIDSmap)
• Opioid substitution treatment increases chances that people who inject drugs will have good adherence to HIV therapy.  (April 2015, AIDSmap)
• PrEP and Drug Resistance: Cause for Concern?  (April 2015, Beta Blog)
• Good mental health associated with excellent adherence among people taking ART for prevention.  (March 2015, AIDSmap)
• Adherence Tips and Tools.  (March 2015, Poz)
• Text message reminders did not improve ART adherence.  (February 2015, Healio)
• Week-on, weekend-off treatment controls viral load in young people.  (February 2015, AIDSmap)
• Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study.  (February 2015, AIDSmap)
• Failed VOICE PrEP Trial Failed to Preempt Lies About Adherence.  (February 2015, Poz)
• Switching Pharmacies Is an Option if Your Pharmacy Gets in the Way of Your Adherence.  (October 2014, TheBody)
• Behavioural and financial incentives may improve HIV treatment outcomes.  (October 2014, AIDSmap)
• Do I Have to Take My HIV Meds at the Same Time Every Day?  (October 2014, TheBody)
• Analysis of PrEP Data Shows High Adherence in U.S., and Among Most at Risk of HIV.  (October 2014, TheBody)
• PrEP will need high adherence, high effectiveness and high coverage in specific populations to be affordable in the US, New York study finds.  (October 2014, AIDSmap)
• Americans Adhered Well to PrEP in Global iPrEx Study.  (September 2014, Poz)
• Stigma, ambivalence and other priorities – explaining poor adherence to PrEP and vaginal microbicides.  (September 2014, AIDSmap)
• CBT counselling significantly increases adherence among participants in HIV PrEP study.  (August 2014, AIDSmap)
• Pill A, Pill B: Simplified Second-Line Treatment for Low-Income Countries.  (August 2014, HIV Treatment Bulletin)
• Study on Intermittent Dosing of PrEP Suggests High Adherence.  (July 2014, Poz)
• High levels of adherence to study medication among women who conceived during HIV PrEP study.  (July 2014, AIDSmap)
• Strong Link Between Taking PrEP Daily and Preventing HIV.  (June 2014, Poz)
• Benefits of a Lowered HIV Pill Burden and Dosing Schedule.  (April 2014, Poz)
• PrEP Adherence Varies Greatly Between Cities.  (March 2014, Poz)
• Very different levels of PrEP uptake and adherence in three US cities, demonstration project finds.  (March 2014, AIDSmap)
• PrEP Adherence Issues Kick Off CROI 2014. (March 2014, Beta Blog)
• A Patient’s Race Affects How HIV Docs Discuss Adherence.  (February 2014, Poz)
• Higher pill burden is associated with poorer adherence to HIV therapy and reduced chances of achieving an undetectable viral load.  (January 2014, AIDSmap)
• Computerised counselling for patients taking HIV therapy can reduce viral load, improve treatment adherence and reduce rates of risky sex.  (January 2014, AIDSmap)
• African studies identify strategies for improving treatment adherence, retention in care.  (January 2014, AIDSmap)
• Worldwide, Employment Is Linked to HIV Drug Adherence.  (December 2013, Poz)
• Good adherence to HIV treatment, undetectable viral load, reduce the risk of anal infection with high-risk HPV types for MSM with HIV.  (December 2013, AIDSmap)
• Six Approaches to Improving Long-Term HIV Treatment Adherence.  (December 2013, TheBodyPro)
• Is Your Patient’s HIV Diagnosis Truly New? Antiretroviral Drug Testing May Provide Verdict.   (November 2013, TheBodyPro)
• Rates of Failure in HIV Drugs Vary Widely in Poorer Nations.  (November 2013, Poz)
• Long-Acting HIV Drugs Could Extend Lives of Low Adherers.  (November 2013, Poz)
• HIV Pill Burden, Not Dosing Frequency, Appears to Affect Treatment Success.  (October 2013, TheBodyPro)
• Solving the HIV Treatment Adherence Enigma.  (October 2013, TheBodyPro)
• Young people (15 to 24 years) especially likely to drop out of HIV care.  (October 2013, AIDSmap)
• Long-acting antiretrovirals may improve survival for people with poor adherence.  (October 2013, AIDSmap)
• Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation.  (September 2013, AIDSmap)
• PrEP Adherence Curbs HIV Transmission in Straight Couples.  (September 2013, Poz)
• Systematic review confirms that regular viral load monitoring assists adherence to HIV therapy.  (September 2013, AIDSmap)
• Drinking alcohol doesn’t increase the risk of HIV treatment failure.  (July 2013, AIDSmap)
• Women’s PrEP Trial Interventions Fail to Protect From HIV.  (March 2013, Poz)
• US gay youth PrEP study meets recruitment and adherence problems. (March 2013, AIDSmap)
• Text Messages May Not Improve Adherence to HIV Medications.  (January 2013, Poz)
• Generic HIV Meds Could Save U.S. $1B a Year, But Risk Lowering Adherence.  (January 2013, Poz)